Evidence map›Paper›PMID 37079095›Full record

ArticleSurgical endoscopy2023

Efficacy and predictive factors of endoscopic ultrasound-guided ethanol ablation in benign solid pancreatic tumors.

Jin Ho Choi, Woo Hyun Paik, Sang Hyub Lee, Min Woo Lee, In Rae Cho, Ji Kon Ryu, Yong-Tae Kim

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Surgical endoscopy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jin Ho ChoiDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, South Korea.
Woo Hyun PaikDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Sang Hyub LeeDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Min Woo LeeDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
In Rae ChoDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Ji Kon RyuDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Yong-Tae KimDepartment of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea. yongtkim@snu.ac.kr.
Seoul National University · KRSungkyunkwan University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDS AND

objectivesEndoscopic ultrasound-guided ethanol ablation (EUS-EA) has recently been introduced for the management of solid pancreatic tumors, including pancreatic neuroendocrine tumors (PNETs) and solid pseudopapillary tumors (SPTs). The study aims to evaluate the efficacy and predictive factors for response of EUS-EA in solid pancreatic tumors.

methodsBetween October 2015 and July 2021, 72 patients who underwent EUS-EA for solid pancreatic tumors were included. The study outcomes were to evaluate the efficacy of EUS-EA with complete remission (CR) and objective response, and their predictive factors.

resultsDuring follow-up, 47 patients were diagnosed with PNETs and 25 with SPTs. Eight cases reached CR and 48 reached objective response. When compared with SPTs, PNETs showed similar duration to reach CR (median not reached; p = 0.319), but shorter duration to reach objective response (PNETs: median 20.6 months, 95%CI 10.26-30.88; SPTs: median 47.7 months, 95%CI 18.14-77.20; p = 0.018). Ethanol dosage > 0.35 ml/cm

conclusionEUS-EA for pancreatic solid lesions seems feasible as a local treatment for patients who refuse or are unfit for surgery. Additionally, PNETs seem to be the better candidate for EUS-EA.

Indexed as

Neuroectodermal Tumors, PrimitiveNeuroendocrine TumorsPancreatic NeoplasmsEndosonographyEthanolHumansUltrasonography, InterventionalEthanolEndoscopic ultrasoundEthanol ablationPancreatic neuroendocrine tumorSolid pseudopapillary tumor

Identifiers

PMID37079095
PMCPMC10338579
OpenAlexW4366463353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.